Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 9.03 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.40 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 47.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 103.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 506.00 Mn |
| 10 | Amylyx Pharmaceuticals | 1.94 Bn | 1.94 Bn | - | 110.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.56 Mn |
| Dec 31, 2025 | 94.57 Mn |
| Sep 30, 2025 | 93.33 Mn |
| Jun 30, 2025 | 89.14 Mn |
| Mar 31, 2025 | 85.70 Mn |
| Dec 31, 2024 | 68.14 Mn |
| Sep 30, 2024 | 68.09 Mn |
| Jun 30, 2024 | 68.02 Mn |
| Mar 31, 2024 | 67.85 Mn |
| Dec 31, 2023 | 69.99 Mn |
| Sep 30, 2023 | 69.75 Mn |
| Jun 30, 2023 | 70.13 Mn |
| Mar 31, 2023 | 70.86 Mn |
| Dec 31, 2022 | 58.50 Mn |
| Sep 30, 2022 | 58.53 Mn |
| Jun 30, 2022 | 58.28 Mn |
| Mar 31, 2022 | 51.60 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 6.76 Mn |
| Jun 30, 2021 | 6.43 Mn |